Glicmiz PF 1mg/500mg/15mg Tablet
Marketer
Auriga Labs
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glicmiz PF 1mg/500mg/15mg Tablet
Combiflor DM 1mg/500mg/15mg tablets offer a multi-component approach to managing blood glucose. This medication, used alongside diet and physical activity, enhances blood sugar regulation in adult patients with type 2 diabetes. It facilitates improved insulin utilization, consequently reducing elevated blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combiflor DM 1mg/500mg/15mg tablets. Ingestion with food minimizes potential stomach discomfort. Should you miss a dose, take it promptly; however, if your next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should also seek medical counsel before use. Kidney function tests will be assessed by your doctor before initiating therapy. Limit alcohol consumption while taking this medication to mitigate the risk of adverse reactions.
Uses of Glicmiz PF 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glicmiz PF 1mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Glicmiz PF 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Glicmiz PF 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glicmiz PF 1mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glicmiz PF 1mg/500mg/15mg Tablet with food.
How Glicmiz PF 1mg/500mg/15mg Tablet works:
Glicmiz PF 1mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when single or dual-agent therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glicmiz PF 1mg/500mg/15mg Tablet with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glicmiz PF 1mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Using Glicmiz PF 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glicmiz PF 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Glicmiz PF 1mg/500mg/15mg tablets, as dosage modification may be necessary. Medical advice should be sought. Glicmiz PF 1mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glicmiz PF 1mg/500mg/15mg Tablet :
Should you forget a Glicmiz PF 1mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glicmiz PF 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Medication for diabetes |
3,018 People bought this recently